mini posts
FeedPosted Oct 23rd 2007 11:30AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Kellogg Co (K), ConocoPhillips (COP), Texas Instruments (TXN), ValueClick Inc (VCLK)
.gif)
MOST NOTEWORTHY: Texas Instruments, Check Point, Mobile Mini, Vineyard National Bancorp and TorreyPines were today's noteworthy downgrades:
- Jefferies downgraded shares of Texas Instruments (NYSE: TXN) to Hold from Buy, as they believe the company's fundamentals are weakening given the worse than anticipated share losses in the wireless segment. Shares were also lowered to Neutral from Overweight at JP Morgan, to Equal Weight from Overweight at Lehman, to Neutral from Outperform at Credit Suisse, and to Neutral from Buy at UBS to reflect the slowdown in the company's wireless growth.
- Check Point Software (NASDAQ: CHKP) was downgraded to Hold from Buy at Jefferies on valuation and highlights the difficult spending environment in 1H08 as well as the company's tough comps.
- Deutsche Bank downgraded shares of Mobile Mini (NASDAQ: MINI) to Hold from Buy following the company's negative preannouncement.
- Oppenheimer lowered Vineyard National Bancorp (NASDAQ: VNBC) to Neutral from Buy to reflect slower pace of balance sheet growth and lower gain-on-sale income estimates.
- JMP Securities downgraded TorreyPines (NASDAQ: TPTX) to Market Outperform from Strong Buy and said Tezampanel's lack of dose response and statistically significant pain free response will keep the stock in the "show me" category.
OTHER DOWNGRADES:
Posted Jul 19th 2007 11:15AM by Kevin Shult (RSS feed)
Filed under: Before the bell, Analyst reports, Analyst upgrades and downgrades, Alcoa Inc (AA)
MOST NOTEWORTHY: Alcoa (AA), Rigel Pharma (RIGL), Isis Pharma (ISIS), Cytokinetics (CYTK) and F5 Networks (FFIV) were today's noteworthy initiations:
- RBC believes shares are expensive, but feels Alcoa (NYSE: AA) has put itself in play and a bid for the company is possible. The firm resumed coverage with a Sector Perform rating and a $51 target.
- Credit Suisse initiated Rigel Pharmaceuticals (NASDAQ: RIGL) with an Outperform rating, believing R788 in ITP alone justifies current value, while RA and pipeline provide potential upside.
- Isis Pharmaceuticals (NASDAQ: ISIS) was initiated with a Buy rating and $17 target at Jefferies; the firm believes Isis's pipeline holds promise and appears under appreciated at the current valuation.
- Credit Suisse is positive on Cytokinetics (NASDAQ: CYTK) congestive heart failure candidate CK-453 and views the market as undeserved, starting shares with an Outperform rating and $15 target.
- Unterberg initiated shares of F5 Networks (NASDAQ: FFIV) with a Market Perform based on valuation...
OTHER INITIATIONS:
- Banc of America started Grant Prideco (NYSE: GRP) share with a Buy rating and $67 target.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).Posted May 22nd 2007 10:59AM by Kevin Shult (RSS feed)
Filed under: Before the bell, Black and Decker (BDK), Analyst initiations, salesforce.com inc (CRM)
MOST NOTEWORTHY: Salesforce.com, Inc (CRM), Black & Decker Corp (BDK), GenVec, Inc (GNVC) and RightNow Technologies (RNOW) were today's noteworthy initiations:
- With customers wanting an alternative to Microsoft (MSFT), Salesforce.com (NYSE: CRM) is making an attempt to be that alternative. It is rumored that management is in talks with Google (GOOG) about the two companies working together, a move that could include offering Google Apps via the AppExchange and integrating more closely those apps with Salesforce.com. Baird initiated shares of Salesforce.com with a Neutral rating and $49 target.
- Banc of America sees major headwinds from declining construction and slower consumer spending on housing and started shares of Black & Decker Corp (NYSE: BDK) with a Sell rating and $85 target.
- Merriman sees upside from strong mid- and late-stage clinical programs, key collaborations and potential for revenue generation, starting shares of GenVec (NASDAQ: GNVC) with a Buy rating.
- Baird finds Rightnow Technology (NASDAQ: RNOW) to be well-positioned within the customer service segment of the CRM market with above average L-T prospects and views the recent uncertainty as a buying opportunity. Baird started shares of RightNow with an Outperform rating and $19 target...
OTHER INITIATIONS:
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).
Why do we have a weak dollar?
Holiday hiring slow for retailers
Closing Bell: What sell-off? (AIG, ABK, EPR, MBI, JAVA, ORCL, ERTS)
